A pilot study of Galectin-3 targeting in chronic kidney fibrosis and kidney function decline

By afschroeder • June 16, 2026

Qin A, Zhou W, Zhang Z, Zhou Q, Wang J, Wang Z, Zhou Z, Sun Q, Su L, Peng Z. A pilot study of Galectin-3 targeting in chronic kidney fibrosis and kidney function decline. BMC Nephrol. 2026 Jun 15. doi: 10.1186/s12882-026-05123-5. Epub ahead of print. PMID: 42298444.

Tags: Cardiology/Epi, Chronic kidney disease, Galectin-3, GB1107, Kidney fibosis, kidney injury, Post Doc, Publications

Understanding Cardiac Anatomy and Imaging to Improve Safety of Procedures: The Right Ventricular Outflow Tract, Part 1

Miyazaki Y, Rimmer M, Hanna P, Park YM, Miyazaki K, Yamagami S, Shivkumar K, Mori S. Understanding Cardiac Anatomy and Imaging to Improve Safety of[...]

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan[...]

National Midterm Outcomes of Ex-Vivo Heart Perfusion in Heart Transplantation

Song J, Cho PD, Zappacosta H, White JP, McKay S, Daniel M, Abramov A, Girish A, Telesca D, Husain M, Ardehali A. National Midterm Outcomes[...]